These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33813459)

  • 1. APPLICATION OF ANTIBIOTICS AND PROBIOTICS FOR PREVENTION OF ANTIBIOTIC-ASSOCIATED DISBIOSIS IN PATIENTS WITH GENERALIZED PERITONITIS AND ENTERAL DYSFUNCTION SUPPORTS STAFF AWARENESS.
    Polyovyy VP; Sydorchuk RI; Fedonyuk LY; Rotar OV; Polyovyy PV; Chepega IG; Fomin AA
    Wiad Lek; 2021; 74(3 cz 1):508-511. PubMed ID: 33813459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
    Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
    Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
    Hayes SR; Vargas AJ
    Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
    Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
    J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Antiobiotic-Induced Disbiosis and Its Correction with Probiotics on Myocardial Tolerance to Ischemia-Reperfusion Injury in SPF Rats.
    Borshchev YY; Sinitsa AV; Zakharchenko MM; Borshchev VY; Burovenko IY; Galagudza MM
    Bull Exp Biol Med; 2019 Feb; 166(4):440-443. PubMed ID: 30788733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics in the add-on treatment of pharyngotonsillitis: a clinical experience.
    La Mantia I; Gelardi M; Drago L; Aragona SE; Cupido G; Vicini C; Berardi C; Ciprandi G;
    J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 1):11-18. PubMed ID: 33426861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii ameliorates gut dysbiosis associated cognitive decline.
    Roy Sarkar S; Mitra Mazumder P; Chatterjee K; Sarkar A; Adhikary M; Mukhopadhyay K; Banerjee S
    Physiol Behav; 2021 Jul; 236():113411. PubMed ID: 33811908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans.
    Wang ZJ; Chen XF; Zhang ZX; Li YC; Deng J; Tu J; Song ZQ; Zou QH
    Microb Pathog; 2017 Aug; 109():156-161. PubMed ID: 28552806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review.
    McFarland LV
    BMJ Open; 2014 Aug; 4(8):e005047. PubMed ID: 25157183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic Supplementation During the Perinatal and Infant Period: Effects on Gut Dysbiosis and Disease.
    Navarro-Tapia E; Sebastiani G; Sailer S; Toledano LA; Serra-Delgado M; García-Algar Ó; Andreu-Fernández V
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32727119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in the add-on treatment of rhinosinusitis: a clinical experience.
    La Mantia I; Gelardi M; Drago L; Aragona SE; Cupido G; Vicini C; Berardi C; Ciprandi G;
    J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 1):27-34. PubMed ID: 33426863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
    Elangovan A; Allegretti JR; Fischer M
    Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
    [No Abstract]   [Full Text] [Related]  

  • 16. Probiotics in the add-on treatment of laryngotracheitis: a clinical experience.
    La Mantia I; Gelardi M; Drago L; Aragona SE; Cupido G; Vicini C; Berardi C; Ciprandi G;
    J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 1):35-40. PubMed ID: 33426864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
    Singh D; Khan MA; Siddique HR
    Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics protect against gut dysbiosis associated decline in learning and memory.
    Roy Sarkar S; Mitra Mazumder P; Banerjee S
    J Neuroimmunol; 2020 Nov; 348():577390. PubMed ID: 32956951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [INFLUENCE OF PROBIOTIC STRAIN E. FAECIUM L3 ON MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY IN THE MODEL OF ANTIBIOTIC-INDUCED INTESTINAL DYSBIOSIS].
    Borshcev YY; Minasian SM; Burovenko IY; Ermolenko EI; Suvorov AN; Galagudza MM
    Ross Fiziol Zh Im I M Sechenova; 2016 Nov; 102(11):1323-32. PubMed ID: 30193448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.